Lōkahi Therapeutics partners with Pepperdine on pipeline program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Lōkahi Therapeutics partners with Pepperdine on pipeline program

Lōkahi Therapeutics™ Expands ai² Pipeline™ Program Through Collaboration with Pepperdine E2B™

September 25, 2026 9:00 AM EDT

RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)-- Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced that it will partner with Pepperdine E2B (Education to Business) to engage students in its ai2 Pipeline initiative during the upcoming academic year. The collaboration is intended to provide students with hands-on experience evaluating real-world biopharmaceutical opportunities while supporting Lkahi's ongoing efforts to identify and assess therapeutic assets through its ai2 platform.

The Pepperdine collaboration will begin with a project involving full-time MBA students in a marketing course taught by Professor... More